Fidelity Equity-Income Fund - Class K (FEIKX) investicinio fondo vieneto kaina ir naujienos

PagrindinisFEIKX • Investiciniai fondai

Fidelity Equity-Income Fund - Class K

89,01 $

02-12 · USD · MUTF · Atsisakymas

Fidelity Equity-Income Fund

89,10 $

FEQIX0,86 %

Fidelity Advisor Strategic Dividend & Income Fund - Class M

18,69 $

FTSDX0,53 %

Fidelity Advisor Multi-Asset Income Fund - Class A

16,03 $

FWATX0,74 %

Fidelity Advisor® Global Equity Income Fund Class A

25,86 $

FGEEX0,84 %

Fidelity Advisor Multi-Asset Income Fund - Class C

16,01 $

FWBTX0,68 %

Fidelity Advisor Strategic Dividend & Income Fund - Class A

18,70 $

FASDX0,48 %

Fidelity Advisor Multi-Asset Income Fund - Class M

16,05 $

FAZYX0,68 %

Fidelity Advisor Multi-Asset Income Fund - Class I

16,04 $

FAYZX0,68 %

Fidelity Advisor Strategic Dividend & Income Fund - Class I

18,81 $

FSIDX0,53 %

Fidelity Equity-Income K6 Fund

19,39 $

FEKFX0,87 %

Investicinis fondas

Ankstesnė uždarymo kaina

89,78 $

Grąža nuo einamųjų metų pradžios

3,69 %

Išlaidų rodiklis

0,46 %

Kategorija

US Equity Large Cap Value

„Morningstar“ įvertis

Grynasis turtas

737,32 mln. USD

Pelningumas

1,65 %

Pirminės apkrovos mokestis

Pradžios data

2008-05-09

Rinkos naujienos

KARK

prieš 6 valandas

Asia shares mostly lower after sharp Wall Street losses on AI-related worries

Business Wire

prieš 1 dieną

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15min.lt

prieš 1 dieną

„Apollo Group“ planuoja išleisti obligacijas ir jas listinguoti „Nasdaq“ biržoje

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

Neurocrine Biosciences Enters New Growth Phase With Broader Revenue Mix

3 Historically Cheap Software Stocks Begging to Be Bought Amid the Recent Tech Rout